NCL
Nucleolin
Also known as: C23, Nsr1, NUCL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P19338
- Gene
- NCL
- Ensembl
- ENSG00000115053
- Chromosome
- 2
- Canonical length
- 710 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome
OverviewNCBI Gene
Nucleolin (NCL), a eukaryotic nucleolar phosphoprotein, is involved in the synthesis and maturation of ribosomes. It is located mainly in dense fibrillar regions of the nucleolus. Human NCL gene consists of 14 exons with 13 introns and spans approximately 11kb. The intron 11 of the NCL gene encodes a small nucleolar RNA, termed U20. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
710 residues, UniProt reviewed canonical sequence.
>P19338|NCL
1 MVKLAKAGKN QGDPKKMAPP PKEVEEDSED EEMSEDEEDD SSGEEVVIPQ KKGKKAAATS
61 AKKVVVSPTK KVAVATPAKK AAVTPGKKAA ATPAKKTVTP AKAVTTPGKK GATPGKALVA
121 TPGKKGAAIP AKGAKNGKNA KKEDSDEEED DDSEEDEEDD EDEDEDEDEI EPAAMKAAAA
181 APASEDEDDE DDEDDEDDDD DEEDDSEEEA METTPAKGKK AAKVVPVKAK NVAEDEDEEE
241 DDEDEDDDDD EDDEDDDDED DEEEEEEEEE EPVKEAPGKR KKEMAKQKAA PEAKKQKVEG
301 TEPTTAFNLF VGNLNFNKSA PELKTGISDV FAKNDLAVVD VRIGMTRKFG YVDFESAEDL
361 EKALELTGLK VFGNEIKLEK PKGKDSKKER DARTLLAKNL PYKVTQDELK EVFEDAAEIR
421 LVSKDGKSKG IAYIEFKTEA DAEKTFEEKQ GTEIDGRSIS LYYTGEKGQN QDYRGGKNST
481 WSGESKTLVL SNLSYSATEE TLQEVFEKAT FIKVPQNQNG KSKGYAFIEF ASFEDAKEAL
541 NSCNKREIEG RAIRLELQGP RGSPNARSQP SKTLFVKGLS EDTTEETLKE SFDGSVRARI
601 VTDRETGSSK GFGFVDFNSE EDAKAAKEAM EDGEIDGNKV TLDWAKPKGE GGFGGRGGGR
661 GGFGGRGGGR GGRGGFGGRG RGGFGGRGGF RGGRGGGGDH KPQGKKTKFELocalizationUniProt · AlphaFold · HPA
Whether an antibody against NCL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 348 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 348 nTPM
- thymus: 323 nTPM
- tonsil: 308 nTPM
- bone marrow: 284 nTPM
- lymph node: 271 nTPM
- urinary bladder: 253 nTPM
Single-cell type
- erythrocyte progenitors: 1,065 nCPM
- megakaryocyte progenitors: 874 nCPM
- esophageal basal cells: 744 nCPM
- megakaryocyte-erythroid progenitors: 711 nCPM
- basal keratinocytes: 704 nCPM
- fallopian secretory cells: 676 nCPM
Immune cell
- NK-cell: 179 nTPM
- MAIT T-cell: 153 nTPM
- total PBMC: 151 nTPM
- gdT-cell: 137 nTPM
- naive CD4 T-cell: 131 nTPM
- myeloid DC: 131 nTPM
Brain region
- hypothalamus: 210 nTPM
- medulla oblongata: 207 nTPM
- basal ganglia: 196 nTPM
- thalamus: 191 nTPM
- white matter: 190 nTPM
- midbrain: 189 nTPM
ReferencesPubMed · IEDB
Publications for NCL from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
7 publications
- Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association.
1996 · Br J Dermatol · RCR 2 · 68 citations - Internalization of anti-nucleolin antibody into viable HEp-2 cells.
1996 · Mol Biol Rep · RCR 1.4 · 62 citations - Antibodies against nucleolin in recipients of organ transplants.
2011 · Transplantation · RCR 1 · 32 citations - Autoantibodies to nucleolin in systemic lupus erythematosus and other diseases.
1991 · J Immunol · RCR 0.8 · 34 citations - Abnormalities in the NC1 domain of collagen type IV in GBM in canine hereditary nephritis.
1989 · Kidney Int · RCR 0.7 · 19 citations
Show 2 more
- Autoantibodies to nucleolin cross-react with histone H1 in systemic lupus erythematosus.
1992 · Mol Biol Rep · RCR 0.3 · 10 citations - Detection of Novel Autoantibodies to Nucleolin's RNA-binding Domains as a Serum Tumor Biomarker Through ELISA.
2022 · Iran J Allergy Asthma Immunol · RCR 0.2 · 2 citations
Reference: T cellIEDB
1 publication
- Mesothelin- and nucleolin-specific T cells from combined short peptides effectively kill triple-negative breast cancer cells.
2024 · BMC Med · RCR 1.1 · 7 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.85
- DepMap mean gene effect
- -0.94
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- cellular response to epidermal growth factor stimulus
- cellular response to leukemia inhibitory factor
- negative regulation of insulin receptor signaling pathway
- negative regulation of translation
- positive regulation of mRNA splicing, via spliceosome
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription of nucleolar large rRNA by RNA polymerase I
Molecular functions
- DNA topoisomerase binding
- identical protein binding
- insulin receptor substrate binding
- mRNA 5'-UTR binding
- PH domain binding
- RNA binding
- telomeric DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- RNA recognition motif domain, eukaryotic-type
- Nucleotide-binding alpha-beta plait domain superfamily
- RNA-binding domain superfamily
- RNA recognition motif
- Nucleolin, RNA recognition motif 1
- Nucleolin, RNA recognition motif 2
- Nucleolin, RNA recognition motif 3
- Nucleolin, RNA recognition motif 4
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NCL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NCL as an antibody target. Whether an autoantibody or antibody against NCL could matter depends on whether native NCL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NCL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NCL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...